TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Clearinghouse Role Broadened By Upton; Asked To Consider All Data In Risk Assessment November 11, 1977